Diagnostic Biochips, Inc.
DBC is redefining measurement in medicine with our proprietary biosensors that permit the direct and continuous monitoring of critical drugs and biomarkers.
Diagnostic Biochips, Inc. (“DBC” or “Company”) is a Maryland-based biosensor platform technology firm that is redefining measurement in medicine. The Company has developed a proprietary sensor ‘functionalization’ process and a suite of biosensors that are set to transform the medical monitoring process. Its paradigm-shifting sensors are a cost-effective method for the direct and continuous monitoring of medically important chemicals.